Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease
Top Cited Papers
- 28 January 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (3), 405-409
- https://doi.org/10.1161/01.cir.0000051361.69808.3a
Abstract
Background— There is an ongoing debate as to whether the gastrointestinal safety of COX-2 inhibition compared with nonsteroidal antiinflammatory drugs (NSAIDs) may come at the cost of increased car...Keywords
This publication has 25 references indexed in Scilit:
- Unusual Form of Truncus Arteriosus Associated With 22q11 DeletionCirculation, 2002
- Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2Science, 2002
- Generation of C-Reactive Protein and Complement Components in Atherosclerotic PlaquesThe American Journal of Pathology, 2001
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic LesionsThe American Journal of Pathology, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Nitric Oxide and Vascular DiseaseNew England Journal of Medicine, 1995
- Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice.Journal of Clinical Investigation, 1994
- Suppression of Thromboxane A2but Not of Systemic Prostacyclin by Controlled-Release AspirinNew England Journal of Medicine, 1991